Pathstone Holdings, LLC

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 2011612 ENGLEWOOD, NJ

Position in TAK

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$4,468,745

+$1,095,429 QoQ

Shares Held

241,293

+11.5% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 85.97431338662953.ToString("F0")% Shared 0.38086475778410483.ToString("F0")% None 13.644821855586361.ToString("F0")%

Healthcare · as of Mar 31, 2026

Pathstone Holdings, LLC holds $39,823,834 across 16 Drug Manufacturers - Specialty & Generic names. TAK ranks #4 (11.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	305,467	$7,309,824
2	ZTS	Zoetis Inc.	57,358	$6,780,288
3	TEVA	Teva Pharmaceutical Industries Ltd	164,003	$4,939,769
4	TAK	Takeda Pharmaceutical Co Ltd This page	241,293	$4,468,745
5	ALKS	Alkermes plc.	81,988	$2,899,094
6	UTHR	UNITED THERAPEUTICS Corp	4,828	$2,862,906
7	NBIX	Neurocrine Biosciences Inc	11,857	$1,562,041
8	HLN	Haleon plc	155,748	$1,559,036

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,468,745	241,293	+11.5%	Shares	Sole	2026-05-11
2025-12-31	$3,373,316	216,377	-9.2%	Shares	Defined	2026-02-13
2025-09-30	$3,489,267	238,338	+7.4%	Shares	Other	2025-11-13
2025-06-30	$3,429,830	221,852	+3.3%	Shares	Sole	2025-08-12
2025-03-31	$3,193,465	214,759	-32.1%	Shares	Defined	2025-05-15
2024-12-31	$4,187,970	316,312	-26.6%	Shares	Defined	2025-02-14
2024-09-30	$6,124,212	430,676	+1.0%	Shares	Sole	2024-11-07
2024-06-30	$5,517,563	426,396	-1.3%	Shares	Sole	2024-08-14
2024-03-31	$6,003,021	432,183	+32.6%	Shares	Defined	2024-05-13
2023-12-31	$4,651,248	325,946	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.